Accueil › Myélome multiple › New Jersey › Edison
Essais cliniques pour Myélome multiple à Edison, NJ
22 études pour Myélome multiple recherchent des participants dans et autour de Edison (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Recrutement en coursPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Recrutement en coursPhase 3
- Astera Cancer Care, East Brunswick · à 6 mi
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Recrutement en coursPhase 3
- Astera Cancer Care, East Brunswick · à 6 mi
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Recrutement en coursPhase 3
- MSK Basking Ridge, Basking Ridge · à 15 mi
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Recrutement en coursPhase 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Recrutement en coursPhase 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · à 15 mi
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Recrutement en coursPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Recrutement en coursPhase 3
- MSK Basking Ridge, Basking Ridge · à 15 mi
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Recrutement en coursPhase 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Recrutement en coursPhase 3
- Research Site, East Brunswick · à 6 mi
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Recrutement en coursÉtude observationnelle
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Recrutement en coursPhase 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Recrutement en coursPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Recrutement en coursPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Recrutement en coursPhase 1 précoce
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · à 3 mi
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Recrutement en coursPhase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Recrutement en coursPhase 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · à 3 mi
A Dietary Study for People With Multiple Myeloma
Recrutement en cours
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Recrutement en coursPhase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Recrutement en coursPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · à 15 mi
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Recrutement en cours
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · à 15 mi
Essais pour Myélome multiple dans d'autres villes
- New York City, NY60 études
- Boston, MA42 études
- Atlanta, GA41 études
- Houston, TX38 études
- Durham, NC37 études
- Nashville, TN32 études
- Denver, CO27 études
- Rochester, MN24 études
- St. Louis, MO24 études
- Columbus, OH24 études
- Baldwin Park, CA23 études
- Chicago, IL22 études
Autres études à Edison
- Cancer du sein68 études
- Cancer du poumon non à petites cellules47 études
- Cancer (tous types)33 études
- Cancer de la prostate29 études
- Cancer colorectal23 études
- Cancer du poumon23 études
- Cancer de la vessie21 études
- Cancer métastatique20 études
- Cancer de l'ovaire20 études
- Leucémie aiguë myéloïde20 études
- Cancer de l'endomètre19 études
- Carcinome urothélial (à cellules transitionnelles)18 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.